Technavio has been monitoring the global influenza diagnostics market size and it is poised to grow by USD 1.32 billion during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005661/en/
Technavio has announced its latest market research report titled Global Influenza Diagnostics Market 2020-2024 (Graphic: Business Wire)
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Latest Free Sample Report on COVID-19 Impact
The market is concentrated, and the degree of concentration will decelerate during the forecast period. Abbott Laboratories, Biocartis Group NV, Bio-Rad Laboratories Inc., Danaher Corp., DiaSorin Spa, GenMark Diagnostics Inc., Meridian Bioscience Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The growing demand for POCT has been instrumental in driving the growth of the market. However, the lack of laboratory infrastructure in developing regions might hamper market growth.
Influenza Diagnostics Market 2020-2024 : Segmentation
Influenza Diagnostics Market is segmented as below:
Hospitals And Diagnostic Laboratories
Academic And Research Centers
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44375
Influenza Diagnostics Market 2020-2024 : Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our influenza diagnostics market report covers the following areas:
Influenza Diagnostics Market size
Influenza Diagnostics Market trends
Influenza Diagnostics Market industry analysis
This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years.
Influenza Diagnostics Market 2020-2024 : Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the influenza diagnostics market, including some of the vendors such as Abbott Laboratories, Biocartis Group NV, Bio-Rad Laboratories Inc., Danaher Corp., DiaSorin Spa, GenMark Diagnostics Inc., Meridian Bioscience Inc., Quidel Corp., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the influenza diagnostics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Influenza Diagnostics Market 2020-2024 : Key Highlights
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist influenza diagnostics market growth during the next five years
Estimation of the influenza diagnostics market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the influenza diagnostics market
Analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of influenza diagnostics market vendors
Table Of Contents :
Value chain analysis
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by End-user
Comparison by End-user
Hospitals and diagnostic laboratories - Market size and forecast 2019-2024
Academic and research centers - Market size and forecast 2019-2024
Home care - Market size and forecast 2019-2024
Market opportunity by End-user
Market Segmentation by Type
Comparison by Type
Point-of-care testing - Market size and forecast 2019-2024
Immunodiagnostics - Market size and forecast 2019-2024
Molecular diagnostics - Market size and forecast 2019-2024
Market opportunity by Type
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Market positioning of vendors
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Scope of the report
Currency conversion rates for US$
List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200804005661/en/